Related Experiment Video
Updated: Mar 21, 2026
06:26
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
2.0K
Glucose-sensitive polymer nanoparticles for self-regulated drug delivery
Li Zhao1, Chunsheng Xiao2, Liyan Wang1
1Laboratory of Building Energy-Saving Technology Engineering, College of Material Science and Engineering, Jilin Jianzhu University, Changchun 130118, P. R. China.
Chemical Communications (Cambridge, England)
|May 20, 2016
Summary
Glucose-sensitive drug delivery systems offer automated diabetes treatment. This review explores systems using glucose oxidase, concanavalin A, and phenylboronic acid, highlighting their potential and challenges.
Area of Science:
- Biomedical Engineering
- Materials Science
- Endocrinology
Background:
- Self-regulated drug delivery systems are crucial for managing diabetes.
- Current systems aim to automatically adjust drug release based on glucose levels, improving patient quality of life.
Purpose of the Study:
- To review recent advancements in glucose-sensitive nanoscale drug delivery systems.
- To discuss the challenges and opportunities associated with these systems.
Main Methods:
- Review of literature on glucose-sensitive drug delivery systems.
- Focus on systems utilizing glucose oxidase (GOD), concanavalin A (Con A), and phenylboronic acid (PBA).
Main Results:
- Overview of nanoscale drug delivery platforms mediated by GOD, Con A, and PBA.
- Identification of key challenges in developing and implementing these systems.
Conclusions:
- Glucose-sensitive drug delivery holds significant promise for diabetes management.
- Further research is needed to overcome existing challenges and realize the full potential of these technologies.
More Related Videos
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
85
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
85
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
76
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
76
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
73
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
73
01:23Modified-Release Drug Delivery Systems: Classification
204
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
204
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
83
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
83
01:24Modified-Release Drug Delivery Systems: Site-Targeted
74
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74